About this episode
This episode explores the shift in psychedelic drug policy and research, highlighting insights from NPR's brain correspondent Jon Hamilton.
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That’s coming after decades of strict prohibition on psychedelic drug use dating back to President Nixon. So how did we go from that to a psychedelic renaissance? A look into a key institution in the world of psychedelic research may give us some clues. This episode, NPR’s brain correspondent Jon Hamilton shares insight from a recent trip. (No pun intended.) Want more psychedelic content? Catch our episode on ketamine therapy here , or learn why some scientists want to take the trip out of psychedelics here . Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org ! See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
People in this episode
Host: Jon Hamilton
Topics covered
- psychedelics
- brain research
- drug policy
- mental health
- psychedelic renaissance
Keywords
- psychedelics
- brain
- Trump
- Nixon
- research
- therapy
- ketamine
- drug use
Mentioned in this episode
Organizations: NPR
Places: President Trump, President Nixon
More episodes of Short Wave
- Why your sunscreen is finally getting a major upgrade · June 12, 2026 · 10 min
- How a single flu shot could protect you for decades · June 10, 2026 · 11 min
- Your DNA is changing all the time. Here’s why · June 9, 2026 · 14 min
- Inner monologues are still a mystery · June 8, 2026 · 14 min
- Prepare to be baffled by what we don't know about eels · June 5, 2026 · 14 min
- This common garden plant summons wasps as bodyguards · June 3, 2026 · 9 min
Explore listener stats, chart rankings, contacts and more on the Short Wave podcast page.